GREENWOOD VILLAGE, Colo.--(BUSINESS WIRE)--BioMimetix JV, LLC, a clinical-stage biotechnology company developing metalloporphyrins, a novel drug class for the treatment of cancer patients, today announced that data from its Phase 2 study of lead candidate
- European patent provides composition of matter and medical use protection for the Company’s proprietary deuterated psilocybin analog and deuterated DMT programs - - New European patent further strengthens intellectual property portfolio, which now in
Mithra to receive EUR 1.5 million milestone payout as a result of the signing of the agreement Additional licensing payout of EUR 15.55 million in regulatory and sales milestones, along with tiered royalties on annual net sales Searchlight anticipates
Presentations Will Feature Studies Evaluating MIEBO™ (Perfluorohexyloctane Ophthalmic Solution), IC-8® Apthera™ IOL and ARMOR Surveillance Study Data Company Will Host Six Educational EventsVAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporatio
BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that it will report financial results for the third quarter of 2023 after the ma
WINNIPEG, Manitoba--(BUSINESS WIRE)--Farmers Edge Inc. (“Farmers Edge” or the “Company”) (TSX: FDGE) announced today that the Company’s third quarter 2023 financial results will be released after market close on Wednesday, November 8, 2023. At t
BioStrand Unveils Groundbreaking Retrieval Augmented Generation (RAG)-Based LLM Platform Integrated with Patented HYFT Technology BioStrand's Work Exemplifies the IPA Family's Investment in Advanced AI, Aiding Partners in Developing New Biologics for Pre
Additional US$6.6 million funding commitment for ATI-1701 brings the total program funding awarded to approximately US$14 million These funds along with other potential funding sources, are anticipated to continue to advance the ATI-1701 program toward a
- New United States patent grants offer protection for deuterated analogs of DMT including composition of matter, medical use and synthesis - - Intellectual Property portfolio provides robust protection for most extensive deuterated DMT portfolio in the
Vermillion Growers will produce 10 million pounds of tomatoes next year, grown across 10 acres. Sustainable agriculture practices and cutting-edge solutions from Gakon Netafim, the company’s greenhouse division, will help reduce water and energy cost
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.